Bioengineered Collagen Implant for Urethral Stricture Repair
Primary Purpose
Urethral Stricture
Status
Recruiting
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
Bioengineered collagen implant
Sponsored by
About this trial
This is an interventional device feasibility trial for Urethral Stricture
Eligibility Criteria
Inclusion Criteria:
Adult males with urethral stricture less than 3 cm (anywhere from penile to bulbar urethra not including the membranous urethra) with existing lumen of at least 6 Fr suitable for augmentation urethroplasty. The stricture may be due to trauma or infection.
Exclusion Criteria:
- Known bovine collagen allergy
- Current urinary tract infection
- Chronic renal failure
- Diabeted
- Neurological diseases
- Chronic obstructive pulmonary diseases
- Sleep disturbances
- Depression
- Former cancer treatment
- Smokers
- Recurrent stricture
Sites / Locations
- University of Malaya Medical CenterRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Bioengineered collagen implant
Arm Description
Standard technique of doing a substitution urethroplasty with no modification to the surgical steps. Instead of an autologous oral bucal mucosa graft, the bioengineered collagen implant is sutured to the healty urethral area after incision of the urethra at the stricture location.
Outcomes
Primary Outcome Measures
Urethral patency
A peri-urethrogram will be performed prior to catheter removal.
Secondary Outcome Measures
Voiding symptoms
Participants are filling out the International Prostate Symptom Score (IPSS) questionnaire.
Urine flow
Participants are undergoing an uroflowmetry. This test measures the volume of urine released from the body, the speed with which it is released, and how long the release takes.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05463991
Brief Title
Bioengineered Collagen Implant for Urethral Stricture Repair
Official Title
Bioengineered Collagen Scaffold Implant as an Alternative to Conventional Buccal Mucosa for Substitution Urethroplasty of Distal Urethral Strictures. - A Pilot Stud
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 15, 2022 (Actual)
Primary Completion Date
October 2022 (Anticipated)
Study Completion Date
December 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Regenosca SA
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The field of research for this study is tissue engineering and the utilization of a bioengineered collagen implant as a substitute biomaterial for conventional buccal mucosa in substitution urethroplasty of distal urethral strictures.
Detailed Description
Urethral stricture is defined as the abnormal narrowing of the urethral lumen in the area of the corpus spongiosum. A stricture is the result of ischemic spongiofibrosis manifesting as scar tissue in the corpus spongiosum. Long-term consequences are chronic fistulation through the skin, recurrent sepsis, bladder stones, obstructive uropathy, obstructive nephropathy, and finally renal failure.
Current available surgical techniques for urethral stricture repair require harvesting of grafts from autologous sites resulting in additional risks of complications at the tissue harvest site and additional pain to the patient.
The hypothesis of this study is that the developed bioengineered collagen implant can be used as an alternative biomaterial to buccal mucosa for substitution urethroplasty in urethral stricture patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urethral Stricture
7. Study Design
Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Bioengineered collagen implant
Arm Type
Experimental
Arm Description
Standard technique of doing a substitution urethroplasty with no modification to the surgical steps. Instead of an autologous oral bucal mucosa graft, the bioengineered collagen implant is sutured to the healty urethral area after incision of the urethra at the stricture location.
Intervention Type
Device
Intervention Name(s)
Bioengineered collagen implant
Intervention Description
Urethral stricture repair
Primary Outcome Measure Information:
Title
Urethral patency
Description
A peri-urethrogram will be performed prior to catheter removal.
Time Frame
four weeks post-surgery
Secondary Outcome Measure Information:
Title
Voiding symptoms
Description
Participants are filling out the International Prostate Symptom Score (IPSS) questionnaire.
Time Frame
two months up-to twenty-four months post-surgery
Title
Urine flow
Description
Participants are undergoing an uroflowmetry. This test measures the volume of urine released from the body, the speed with which it is released, and how long the release takes.
Time Frame
two months up-to twenty-four months post-surgery
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult males with urethral stricture less than 3 cm (anywhere from penile to bulbar urethra not including the membranous urethra) with existing lumen of at least 6 Fr suitable for augmentation urethroplasty. The stricture may be due to trauma or infection.
Exclusion Criteria:
Known bovine collagen allergy
Current urinary tract infection
Chronic renal failure
Diabeted
Neurological diseases
Chronic obstructive pulmonary diseases
Sleep disturbances
Depression
Former cancer treatment
Smokers
Recurrent stricture
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mattias Larsson
Phone
+41765973705
Email
larsson@regenosca.com
First Name & Middle Initial & Last Name or Official Title & Degree
Eva-Maria Balet
Phone
+41788687973
Email
balet@regenosca.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Teng Aik Ong, Prof
Organizational Affiliation
University of Malaya Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Malaya Medical Center
City
Kuala Lumpur
ZIP/Postal Code
59100
Country
Malaysia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Teng Aik Ong, Prof
Email
taong@um.edu.my
First Name & Middle Initial & Last Name & Degree
Yeoh Wei Sien
Email
wei.sien@ummc.edu.my
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Bioengineered Collagen Implant for Urethral Stricture Repair
We'll reach out to this number within 24 hrs